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SHORT COMMUNICATION

Size or the Number of Portal Tracts: Which Matters in a Liver
Biopsy Core in Chronic Hepatitis C?
Om Parkash, Khalid Mumtaz, Zubair Ahmed, Saeed Hamid, Fatima Jafri and Wasim Jafri

ABSTRACT
Liver biopsy has an important role in staging of fibrosis (SoF) and grading of inflammation (GoI) in chronic hepatitis C
(CHC) patients. The effect of size and number of portal tracts (NoP) on grading and staging of liver biopsy was evaluated.
A total of 150 consecutive liver biopsy core (LBC) of patients with CHC were obtained. There were 98 (65.3%) males.
Mean length of LBC was 1.45 ± 0.48 cm. Mean number of portal tracts (NoP) was 11±4.6. Mean length of LBC was greater
(1.60±0.45 cm) in stage 4 (n=41; 27.3%) and lesser (1.28+0.39) in stage 1 (n=23; 15%, p=0.04). The mean NoP were 8.5,
10.6 and 13.1 in GoI 1, 2 and 3 respectively (p < 0.001). The mean NoP were 7.6, 11.1, 11.3 and 14.5 in SoF 1, 2, 3 and
4 respectively (p < 0.0001). There was a good correlation between number of portal tracts and length of LBC (r2=0.56).
Key words:

Liver biopsy. Portal tract. Grade. Stage. Fibrosis. Inflammation. Hepatitis C.

Liver biopsy is considered the gold standard for the
evaluation of infectious and non-infectious diseases of
liver. Liver biopsy has an integral role in assessing the
stage of fibrosis (SoF) and grade of inflammation (GoI)
in patients with chronic hepatitis C (CHC) virus infection;
both are important predictors of treatment response and
have therapeutic as well as prognostic implications.1
Generally grading and staging are performed by using
standardized semi-quantitative scoring systems. Ideally,
both the grade and the stage should predict prognosis
and guide therapeutic intervention, although evidence
for this is relatively slight in most chronic liver diseases.2
Usually, the natural history of CHC infection is slow, with
mild inflammatory changes. Chronic hepatitis should be
characterized by etiologic designation as well as grade
and stage of the disease.3
A satisfactory length of liver biopsy has been reported to
range from 1 to 4 cm. A sample 1.5 cm long and/or
containing 4 to 6 portal tracts has been considered
acceptable. There is insufficient literature on the impact
of size of LBC in patients with CHC and most of it is
reported from Western countries.2
The aim of this study was to examine the impact of liver
biopsy core size and number of portal tracts on
assessing the staging of fibrosis (SoF) and grading of
inflammation (GoI) in patients undergoing liver biopsy
for chronic hepatitis C (CHC).
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A total of 150 CHC patients with mean age of 39 ± 14
years who underwent liver biopsy were included. Among
them, 98 (65.3%) were males.
Overall the mean length of liver biopsy core (LBC) was
1.45 ± 0.45 cm. The mean length of LBC was 1.22
± 0.37 cm in GoI 1 (n=17; 11.3%), 1.46 ± 0.5 cm in GoI
2 (n=64; 42.6%) and 1. 5 ± 0.45 cm in GoI 3 (n=69; 46%,
Table I). There was no statistical significance between
length of LBC and grade of inflammation (p= 0.102).
Mean length of LBC was 1.28 ± 0.39 cm, 1.47 ± 0.56 cm,
1.34 ± 0.30 cm and 1.60 ± 0.45 cm in fibrosis stages I
(n=23; 15.3%), II (n=60; 40%), III (n=24;16%) and IV
(n=41; 27.3%) respectively. Mean LBC was significantly
longer (1.60 ± 0.45 cm) in stage IV fibrosis than stage I
(1.28 ±0.39 cm, p= 0.04).
Table I: Distribution of length of liver biopsy core (LBC) with grades
of inflammation and stages of fibrosis.
Grade of
inflammation
I (n= 17)
II (n=64)
III (n=69)

Mean length of
LBC +SD
1.23 ± 0.37 cm
1.44 ± 0.53 cm
1.44 ± 0.49 cm

Stage of
inflammation
I (n=23)
II (n=60)
III (n=26)
IV (n=41)

Mean length of
LBC +SD
1.28 ± 0.39 cm
1.47 ± 0.56 cm
1.34 ± 0.30 cm
1.60 ± 0.45 cm

Overall, the mean number of portal tracts in liver biopsy
core were 11 ± 4.6. The mean number of portal tracts
were 8.5 ± 4.6 in GoI 1 (n=17; 11.3%), 10.6 ± 3.8 in GoI
2 (n=64; 42.6%) and 13.1 ± 4.7 in GoI 3 (n=69; 46%)
with high statistical significance (p < 0.001). The mean
number of portal tracts were 7.6 ± 2.9 in SoF I (n=23;
15.3%), 11.1 ± 4.1 in SoF II (n=60; 40%), 11.3 ± 4.3 in
SoF III (n=24; 16%) and 14.5 ± 4.5 in SoF IV (n=41; 27.3%),
again with high statistical significance (p < 0.001).
Significant correlation was between the length of liver
biopsy core and the number of portal tracts (r2 = 0.53,
p = 0.001, Figure 1).
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Recently a Brazilian study also suggested that validity
can be obtained with fragment length of 2.5 cm and > 10
portal tracts. However, in this study sample size was
relatively smaller as compared to the study by Strauss.6
It can be assumed that the two studies cannot be
compared in terms of demography, alcohol intake and
BMI.

Figure 1: Showing correlation between number of portal tracts and size of
liver biopsy core.

It was found that as the number of portal tracts
increased, severity of GoI also increased significantly;
therefore, reduction in number of portal tracts can result
into underestimation of the grade of inflammation in
chronic hepatitis C patients. Similarly, the stage of
fibrosis is also dependant on the number of portal tracts.
The advancement in stage of fibrosis was directly
proportional to the number of portal tracts in a liver
biopsy core which was statistically significant.

The results of this study suggested that the number of
portal tracts is more important than the size of liver
biopsy core (LBC) in reporting the grade of inflammation
and stage of fibrosis in patients with chronic hepatitis C
infection. LBC size has importance in accurately
establishing the stage of fibrosis but not good-enough in
reporting the grading of inflammation. However, there
was a linear relationship between the number of portal
tracts and the length of liver biopsy core.

It is concluded that number of portal tracts is better in
reliably reporting both the grades of inflammation and
stages of fibrosis as compared to the size of liver biopsy
core in patients with hepatitis C infection. These two
parameters are important in accurately ascertaining
disease status and in predicting the treatment outcomes
and prognosis. Based on this information the need
for reporting number of portal tracts along with the
size of liver biopsy core in a histopathology report is
emphasized.

These results have demonstrated that grade of
inflammation is increasing with the length of LBC but that
difference was not statistically significant (p = 0.159).
Colloredo et al. have shown that reporting milder disease
is common with smaller specimen as compared to larger
with the statistical significant difference,4 which is
contrary to the present results. This could be a chance
finding which can be confirmed in future studies.
Nevertheless, these results had shown that the
increasing length of the LBC has good relationship with
reporting of advanced stage of fibrosis and has
statistical significance (p = < 0.014). Similarly Colloredo
et al. has shown that degree of fibrosis increases with
increase in length of specimen as in this study.4
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